CORXEL Trademark

Trademark Overview


On Thursday, December 19, 2024, a trademark application was filed for CORXEL with the United States Patent and Trademark Office. The USPTO has given the CORXEL trademark a serial number of 79420923. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Wednesday, October 22, 2025. This trademark is owned by Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.. The CORXEL trademark is filed in the Pharmaceutical Products, Advertising, Business and Retail Services, and Computer & Software Services & Scientific Services categories with the following description:

Monitoring pharmaceutical, veterinary and sanitary preparations, medical supplies and drug for quality control purposes; quality control for others; quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the field of pharmaceuticals for the treatment of inflammation, cardiovascular diseases, heart failure, cardiac arrhythmia, coronary heart disease, angina pectoris, myocarditis, hypertension, central nervous system diseases, cerebral hemorrhage, cerebral infarction, metabolic diseases and disorders in the nature of diabetes, kidney diseases, tumors, parasitosis, acariasis, bacterial infection, fungal infection, microbiosis, ophthalmic disorders, rhinopathy, edema, cirrhosis ascites; scientific research and development; chemical research services; pharmaceutical research services; medical and scientific research in the nature of conducting clinical trials for others in the field of inflammation, cardiovascular diseases, heart fai...

Wholesale store services for pharmaceutical and veterinary preparations and medical supplies; retail store services for pharmaceutical and veterinary preparations and medical supplies; wholesale and retail store services featuring medical supplies; wholesale and retail store services featuring medicines; wholesale and retail store services featuring pharmaceutical preparations

Anti-inflammatories; cardiovascular pharmaceutical preparations; medicines for human purposes, namely, medicines for the treatment of degenerative disease, motor neuron disease; medicines for human purposes, namely, medicines for the treatment of epilepsy; medicines for human purposes, namely, medicines for the treatment of cardiovascular disease, coronary heart disease, angina pectoris, myocarditis, cardiac arrhythmia, tumors, infectious diseases, autoimmune disease, blood disease, mental illness, ophthalmic disorders, metabolic diseases and disorders in the nature of diabetes, kidney diseases, osteoporosis; antivirals; medicines for human purposes, namely, biological products, prepared by using biological materials in the nature of microorganisms, cells, and various animal and human tissues and liquids, obtained by biological techniques, namely, genetic engineering, cell engineering, protein engineering, fermentation engineering for the treatment of central nervous system diseases, p...
corxel

General Information


Serial Number79420923
Word MarkCORXEL
Filing DateThursday, December 19, 2024
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateWednesday, October 22, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMonitoring pharmaceutical, veterinary and sanitary preparations, medical supplies and drug for quality control purposes; quality control for others; quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the field of pharmaceuticals for the treatment of inflammation, cardiovascular diseases, heart failure, cardiac arrhythmia, coronary heart disease, angina pectoris, myocarditis, hypertension, central nervous system diseases, cerebral hemorrhage, cerebral infarction, metabolic diseases and disorders in the nature of diabetes, kidney diseases, tumors, parasitosis, acariasis, bacterial infection, fungal infection, microbiosis, ophthalmic disorders, rhinopathy, edema, cirrhosis ascites; scientific research and development; chemical research services; pharmaceutical research services; medical and scientific research in the nature of conducting clinical trials for others in the field of inflammation, cardiovascular diseases, heart failure, cardiac arrhythmia, coronary heart disease, angina pectoris, myocarditis, hypertension, central nervous system diseases, cerebral hemorrhage, cerebral infarction, metabolic diseases and disorders in the nature of diabetes, kidney diseases, tumors, parasitosis, acariasis, bacterial infection, fungal infection, microbiosis, ophthalmic disorders, rhinopathy, edema, cirrhosis ascites; medical and scientific research in the nature of conducting clinical trials for others; medical research services; development of pharmaceutical preparations and medicines; pharmaceutical drug development services; pharmaceutical research and development; research and development services relating to medicines; pharmaceutical product evaluation; testing of pharmaceuticals; packaging design
Goods and ServicesWholesale store services for pharmaceutical and veterinary preparations and medical supplies; retail store services for pharmaceutical and veterinary preparations and medical supplies; wholesale and retail store services featuring medical supplies; wholesale and retail store services featuring medicines; wholesale and retail store services featuring pharmaceutical preparations
Description of MarkThe mark consists of the stylized wording "CORXEL" to the right of a design of an incomplete heart with a helix in the middle.
Goods and ServicesAnti-inflammatories; cardiovascular pharmaceutical preparations; medicines for human purposes, namely, medicines for the treatment of degenerative disease, motor neuron disease; medicines for human purposes, namely, medicines for the treatment of epilepsy; medicines for human purposes, namely, medicines for the treatment of cardiovascular disease, coronary heart disease, angina pectoris, myocarditis, cardiac arrhythmia, tumors, infectious diseases, autoimmune disease, blood disease, mental illness, ophthalmic disorders, metabolic diseases and disorders in the nature of diabetes, kidney diseases, osteoporosis; antivirals; medicines for human purposes, namely, biological products, prepared by using biological materials in the nature of microorganisms, cells, and various animal and human tissues and liquids, obtained by biological techniques, namely, genetic engineering, cell engineering, protein engineering, fermentation engineering for the treatment of central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, antipyretic and analgesic purposes, non-steroidal anti-inflammatory purposes, infectious diseases, autoimmune diseases, anti-tumor purposes, hypoglycemic and diuretic purposes, vitamin and hormonal purposes; medicines for human purposes, namely, parenteral nutrition supplements; pharmaceutical preparations acting on the central nervous system; cerebral hemorrhage prophylactic agents; pharmaceutical preparations for the treatment of heart rhythm disorders; antiarrhythmics; cardiovascular agents for medical purposes; nutritive substances for microorganisms for medical purposes; nutritive substances for microorganism cultures for medical or veterinary purposes; pharmaceutical preparations for the treatment of hypertension; nasal spray preparations; ophthalmic preparations; eye drops; chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of inflammation, cardiovascular diseases, heart failure, cardiac arrhythmia, coronary heart disease, angina pectoris, myocarditis, hypertension, central nervous system diseases, cerebral hemorrhage, cerebral infarction, metabolic diseases and disorders in the nature of diabetes, kidney diseases, tumors, parasitosis, acariasis, bacterial infection, fungal infection, microbiosis, ophthalmic disorders, rhinopathy, edema, cirrhosis ascites; chemico-pharmaceutical preparations, namely, drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; chemico-pharmaceutical preparations, namely, drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; chemico-pharmaceutical preparations, namely, drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; raw material drugs, namely, pharmaceuticals for the treatment of inflammation, cardiovascular diseases, heart failure, cardiac arrhythmia, coronary heart disease, angina pectoris, myocarditis, hypertension, central nervous system diseases, cerebral hemorrhage, cerebral infarction, metabolic diseases and disorders in the nature of diabetes, kidney diseases, tumors, parasitosis, acariasis, bacterial infection, fungal infection, microbiosis, ophthalmic disorders, rhinopathy, edema, cirrhosis ascites; antihypertensives; diuretic preparations; medicines for the treatment of cardiovascular and cerebrovascular diseases; dietetic preparations adapted for medical purposes; dietetic foods and beverages adapted for medical use; dietetic infusions for medical use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 9, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, April 9, 2025
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, April 9, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameJi Xing Pharmaceuticals (Shanghai) Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCN

Trademark Events


Event DateEvent Description
Thursday, April 3, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, April 9, 2025LIMITATION FROM ORIGINAL APPLICATION ENTERED
Wednesday, April 9, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 9, 2025APPLICATION FILING RECEIPT MAILED
Thursday, June 5, 2025ASSIGNED TO EXAMINER
Wednesday, June 25, 2025NON-FINAL ACTION WRITTEN
Thursday, June 26, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, August 11, 2025REFUSAL PROCESSED BY MPU
Tuesday, August 12, 2025NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, August 30, 2025REFUSAL PROCESSED BY IB
Tuesday, October 21, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 21, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 22, 2025TEAS/EMAIL CORRESPONDENCE ENTERED